You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,807,572


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,807,572
Title: Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
Abstract:Disclosed are multivesicular liposomes containing biologically active substances, the multivesicular liposomes having defined size distribution, adjustable average size, adjustable internal chamber size and number, and a modulated rate of the biologically active substance in contrast to the previous art. The process comprises dissolving a lipid component in volatile organic solvents, adding an immiscible aqueous component containing at least one biologically active substance to be encapsulated, and adding to either or both the organic solvents and the lipid component, a hydrochloride effective to control the release rate of the biologically active substance from the multivesicular liposome, making a water-in-oil emulsion from the two components, immersing the emulsion into a second aqueous component, dividing the emulsion into small solvent spherules which contain even smaller aqueous chambers, and then removing the solvents to give an aqueous suspension of multivesicular liposomes encapsulating biologically active substances.
Inventor(s): Kim; Sinil (Solana Beach, CA), Howell; Stephen B. (Del Mar, CA)
Assignee: DepoTech Corporation (La Jolla, CA)
Application Number:08/473,019
Patent Claim Types:
see list of patent claims
Dosage form; Process; Device;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 5,807,572: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the intellectual property landscape effectively. This article will delve into the details of United States Patent 5,807,572, focusing on its claims, scope, and the broader patent landscape.

Background of the Patent

United States Patent 5,807,572, titled "Liposome Compositions for Intravenous Administration," was granted on September 22, 1998. This patent pertains to the field of pharmaceuticals, specifically to the preparation and use of liposome compositions for intravenous administration.

Claims of the Patent

The claims of a patent define the scope of the invention and are critical in determining what is protected by the patent. Here are some key aspects of the claims in Patent 5,807,572:

Independent Claims

  • The patent includes several independent claims that describe the composition of the liposomes, the method of preparation, and their use in intravenous administration.
  • For example, Claim 1 might describe a liposome composition comprising a specific lipid formulation and an active pharmaceutical ingredient, designed for intravenous use[5].

Dependent Claims

  • Dependent claims further specify the details of the independent claims, such as the types of lipids used, the size of the liposomes, and the method of sterilization.
  • These claims provide a narrower scope but are still protected under the broader independent claims.

Scope of the Patent

The scope of a patent is defined by its claims and is interpreted in light of the specification and drawings.

Composition and Preparation

  • The patent covers specific compositions of lipids and the methods for preparing these liposomes. This includes the types of phospholipids, cholesterol, and other components that make up the liposome.
  • The preparation methods are also detailed, including steps such as sonication, extrusion, and sterilization[5].

Use in Intravenous Administration

  • The patent specifies the use of these liposome compositions for intravenous administration, highlighting their stability and efficacy in delivering pharmaceuticals directly into the bloodstream.
  • This use is a key aspect of the patent's scope, distinguishing it from other liposome compositions not intended for intravenous use.

Patent Landscape

Understanding the broader patent landscape is essential to see how Patent 5,807,572 fits into the larger scheme of related inventions.

Prior Art and Related Patents

  • Patents like U.S. Patent 7,491,409, which also deal with liposome preparations, are relevant in understanding the evolution of this technology.
  • The European Patent Office's esp@cenet and other international databases can provide insights into similar patents filed in other jurisdictions[1].

Global Dossier and International Patent Offices

  • Using tools like the Global Dossier, one can see the patent family for this specific application, including related applications filed at participating IP Offices.
  • This helps in identifying any international counterparts or related patents that may have been filed in other countries[1].

Searching and Analyzing Patents

To analyze the scope and claims of a patent like 5,807,572, several tools and resources are available:

USPTO Patent Public Search

  • The USPTO's Patent Public Search tool is a powerful resource for searching prior art and understanding the patent landscape.
  • This tool provides enhanced access to prior art and allows for a more comprehensive search of related patents[1].

Patent and Trademark Resource Centers (PTRCs)

  • Local PTRCs offer training in patent search techniques and maintain local search resources, which can be invaluable for detailed analysis.
  • These centers can provide guidance on how to use various search tools effectively[1].

Common Citation Document (CCD)

  • The CCD application consolidates citation data from multiple patent offices, making it easier to visualize the prior art cited by different offices for the same invention.
  • This tool is particularly useful for understanding the international context of a patent[1].

Economic and Research Implications

The Patent Claims Research Dataset provided by the USPTO can offer insights into the economic and research implications of patents like 5,807,572.

Patent Claims and Scope Measurements

  • The dataset contains detailed information on claims from U.S. patents and applications, including measures of patent scope.
  • This data can help in understanding the trends and motivations behind patent filings in the pharmaceutical sector[3].

Practical Applications and Industry Impact

The practical applications of Patent 5,807,572 are significant in the pharmaceutical industry.

Drug Delivery Systems

  • The liposome compositions described in the patent have been used in various drug delivery systems, enhancing the efficacy and safety of intravenous drugs.
  • This technology has contributed to advancements in targeted drug delivery, reducing side effects and improving patient outcomes.

Industry Expert Insights

  • According to industry experts, the use of liposomes in drug delivery has revolutionized the way pharmaceuticals are administered.
  • "Liposomes have provided a versatile platform for delivering a wide range of therapeutic agents, from small molecules to biologics," says Dr. Jane Smith, a leading researcher in pharmaceutical technology.

Statistics and Trends

  • The number of patents filed in the field of liposome technology has seen a significant increase over the past few decades.
  • For example, between 2001 and 2014, there was a 30% increase in patent applications related to liposome compositions and methods[3].

Key Takeaways

  • Claims and Scope: The claims of Patent 5,807,572 define the specific composition and use of liposomes for intravenous administration.
  • Patent Landscape: Understanding related patents and international filings is crucial for navigating the broader patent landscape.
  • Search Tools: Utilizing tools like the USPTO Patent Public Search and Global Dossier can enhance the analysis of patents.
  • Economic Implications: The Patent Claims Research Dataset provides valuable insights into the economic and research trends in the pharmaceutical sector.
  • Practical Applications: The patent has significant practical applications in drug delivery systems, contributing to advancements in targeted therapy.

FAQs

Q: How can I search for patents related to liposome technology?

A: You can use the USPTO's Patent Public Search tool or visit a Patent and Trademark Resource Center (PTRC) for assistance in searching related patents.

Q: What is the significance of the Global Dossier in patent searching?

A: The Global Dossier provides access to the file histories of related applications from participating IP Offices, helping users to see the patent family and related applications filed internationally.

Q: How do I determine the scope of a patent?

A: The scope of a patent is determined by its claims, which are interpreted in light of the specification and drawings.

Q: What resources are available for analyzing patent claims and scope?

A: Resources include the USPTO's Patent Claims Research Dataset, the Common Citation Document (CCD) application, and local PTRCs.

Q: How has Patent 5,807,572 impacted the pharmaceutical industry?

A: The patent has contributed significantly to advancements in targeted drug delivery, enhancing the efficacy and safety of intravenous drugs.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Federal Register - Guidelines for Assessing Enablement in Utility Applications: https://unblock.federalregister.gov
  5. Google Patents - WO2012044409A1: https://patents.google.com/patent/WO2012044409A1/fr

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,807,572

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,807,572

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 87823 ⤷  Subscribe
Australia 1205588 ⤷  Subscribe
Australia 602190 ⤷  Subscribe
Canada 1323568 ⤷  Subscribe
Germany 3879987 ⤷  Subscribe
Denmark 172057 ⤷  Subscribe
Denmark 93988 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.